Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the public reaction to genetically modified mosquito vaccines by end of 2025?
Mostly Positive • 25%
Mixed • 25%
Mostly Negative • 25%
Indifferent • 25%
Public opinion polls or surveys conducted by reputable organizations
Leiden University Researchers, Funded by Bill Gates, Use Genetically Modified Mosquitoes for Malaria Vaccines, Raising Ethical Concerns
Jan 2, 2025, 02:20 PM
Researchers at Leiden University Medical Center, funded by the Bill & Melinda Gates Foundation with $1,578,317, have developed a novel method for delivering malaria vaccines using genetically modified mosquitoes. These mosquitoes, dubbed 'flying vaccinators,' are engineered to transmit a modified malaria parasite, GA2, to humans through bites. In a study involving 43 participants, conducted over three sessions, the mosquitoes carrying the GA2 parasite provided protection to 88% of the subjects, significantly higher than the 12.5% protection rate observed in the placebo group using the GA1 parasite. The initiative aims to combat malaria, a disease that resulted in 597,000 deaths in 2023 according to the World Health Organization. The research has sparked ethical concerns regarding informed consent, as similar studies have highlighted potential issues with this method of vaccine delivery.
View original story
Mostly Positive • 25%
Indifferent • 25%
Mixed • 25%
Mostly Negative • 25%
Unchanged • 25%
Mostly positive • 25%
Mixed • 25%
Mostly negative • 25%
Major public protests • 25%
Predominantly negative • 25%
Mixed reactions • 25%
Widespread support • 25%
Mostly positive • 25%
Indifferent • 25%
Mixed • 25%
Mostly negative • 25%
No significant response • 25%
Evenly split • 25%
Majority opposed • 25%
Majority supportive • 25%
Decreased Confidence • 25%
Other • 25%
Increased Confidence • 25%
No Change • 25%
Public opinion divided • 25%
Insufficient data • 25%
Majority oppose changes • 25%
Majority support changes • 25%
Mixed opinions • 25%
Increase in support • 25%
Decrease in support • 25%
No change • 25%
None • 25%
1-3 Countries • 25%
4-6 Countries • 25%
More than 6 Countries • 25%
Unsuccessful • 25%
Successful but with some adverse effects • 25%
Successful with no adverse effects • 25%
Inconclusive • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
More than 10 countries • 25%
No countries • 25%
1 to 4 countries • 25%
5 to 10 countries • 25%